Front Row Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33K Hold
318
0.01% 259
2025
Q4
$32.1K Hold
318
0.01% 253
2025
Q3
$39.2K Hold
318
0.01% 239
2025
Q2
$38.2K Hold
318
0.01% 234
2025
Q1
$46.8K Hold
318
0.02% 224
2024
Q4
$51.6K Hold
318
0.02% 215
2024
Q3
$51.8K Hold
318
0.02% 215
2024
Q2
$43.4K Hold
318
0.02% 287
2024
Q1
$48.7K Buy
+318
New +$47.5K 0.02% 261
2021
Q1
Sell
-200
Closed -$40K 956
2020
Q4
$40K Hold
200
0.02% 280
2020
Q3
$41K Hold
200
0.02% 268
2020
Q2
$44K Hold
200
0.03% 233
2020
Q1
$37K Buy
+200
New +$33K 0.03% 252

Other funds holding CLX

Front Row Advisors's CLX Position: Q1 2026 in Review

Front Row Advisors held its Clorox (CLX) position steady in Q1 2026 at 318 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #259.

Front Row Advisors first reported a position in CLX in Q1 2020 and has held it in 13 quarters since. The position peaked at $51.8K in Q3 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Front Row Advisors held 318 shares of Clorox worth $33K as of Q1 2026.
  • Front Row Advisors left its Clorox share count unchanged in Q1 2026.
  • Clorox made up 0.01% of Front Row Advisors's portfolio in Q1 2026, its #259 holding.
  • Front Row Advisors first reported a position in Clorox in Q1 2020 and has held it in 13 quarters since.
  • Front Row Advisors's Clorox position peaked at $51.8K in Q3 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.